Analyst Coverage

Genetic Analysis AS has coverage from the below listed analysts.

Mangold Fondskommision AB

Analyst Jan Glevén

Mangold Fondskommision has issued the following report for the GEAN share:

2023-11-16 Mangold – Genetic Analysis AS – Update Q3 results – EnglishDownload
2023-09-06 Mangold – Genetic Analysis – Update Q2 – EnglishDownload
2023-09-06 Mangold – Genetic Analysis – Update Q2 – SwedishDownload
2023-06-02 Mangold – Genetic Analysis – Update Q1 results – EnglishDownload
2023-06-02 Mangold – Genetic Analysis – Update Q1 results – SwedishDownload
2023-04-24 Mangold – Genetic Analysis – Update Q4 results – EnglishDownload
2023-04-24 Mangold – Genetic Analysis – Update Q4 results – SwedishDownload
2022-11-23 Mangold – Genetic Analysis – Update Q3 resultsDownload
2022-09-13 Mangold – Genetic Analysis – Update Q2 resultsDownload
2022-05-10 Mangold – Genetic Analysis – Initial Coverage – EnglishDownload
2022-05-10 Mangold – Genetic Analysis – Initial Coverage – SwedishDownload

Norne Securities AS

Analyst Gediminas Ruginis

Please note that related to valuation, Norne Securities only issue a range, and not  a target. As Norne Securities state in the reports, this is due to the services being Paid Research, Norne Securities will, under current legislation (Norwegian), not provide a specific research recommendation with respect to the Company’s shares, but will provide a fair value estimate range, from conservative to optimistic, in accordance with market practice for such research.

Norne Securities has issued the following reports for the GEAN share:

2023-03-13 Norne – Genetic Analysis – Q4 2022 Results updateDownload
2022-11-01 Norne – Genetic Analysis – Q3 2022 Results updateDownload
2022-08-26 Norne -Genetic Analysis – Q2 2022 Results updateDownload
2022-06-10 Norne – Genetic Analysis – Initiation of Coverage – EnglishDownload
2022-06-10 Norne – Genetic Analysis – Initiation of Coverage – PresentationDownload